Sai Life Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/02/2026 ,inter alia, to consider and approve Un-audited Financial Results ....
SAILIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sai Life Sciences has informed the stock exchanges that its Board of Directors will meet on Thursday, 5 February 2026. The main agenda is to consider and approve the Un-audited Financial Results (both Standalone and Consolidated) for the Third Quarter and Nine Months ended 31 December 2025. The trading window for company securities has already been closed from 1 January 2026 and will remain shut until 48 hours after the results are declared. The notice was signed by Runa Karan, Company Secretary & Compliance Officer, and was filed with both BSE (Scrip Code 544306) and NSE (Symbol: SAILIFE) on 22 January 2026.
This is a routine regulatory filing and has no direct impact on the stock price. Investors should watch the actual Q3 results due on 5 February 2026 for any material performance updates, as the results will set the tone for the stock in the near term.